These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1265907)

  • 21. The treatment of parkinsonism.
    Godwin-Austen R
    Practitioner; 1975 Oct; 215(1288):445-51. PubMed ID: 1202468
    [No Abstract]   [Full Text] [Related]  

  • 22. Levodopa-induced myoclonus.
    Klawans HL; Goetz C; Bergen D
    Arch Neurol; 1975 May; 32(5):330-4. PubMed ID: 1079721
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drugs for parkinsonism.
    Med Lett Drugs Ther; 1986 Jun; 28(716):62-4. PubMed ID: 3713639
    [No Abstract]   [Full Text] [Related]  

  • 24. [Comparative study on Parkopan, Amantadine and L-dopa in the treatment of Parkinson's disease].
    Dzudza M; Dzudza D
    Med Arh; 1974; 28(4):407-15. PubMed ID: 4613968
    [No Abstract]   [Full Text] [Related]  

  • 25. [Dyskinesia induced by anticholinergic drugs--electrophysiological analysis].
    Mano T
    Rinsho Shinkeigaku; 1974 Mar; 14(3):255-65. PubMed ID: 4153837
    [No Abstract]   [Full Text] [Related]  

  • 26. Neuroleptics and the corpus striatum: clinical implications.
    Stimmel GL
    Dis Nerv Syst; 1976 Apr; 37(4):219-24. PubMed ID: 1253676
    [No Abstract]   [Full Text] [Related]  

  • 27. [Action of amantadine on parkinsonian tremor].
    Agnoli A; Casacchia M; Ruggieri S; Volante F; Accornero N
    Minerva Med; 1971 Oct; 62(82):3990-3. PubMed ID: 5125061
    [No Abstract]   [Full Text] [Related]  

  • 28. [Therapy of Parkinsonism. II].
    Clin Ter; 1974 Nov; 71(4):367-87. PubMed ID: 4617648
    [No Abstract]   [Full Text] [Related]  

  • 29. [Parkinsonism].
    Kadykov AS
    Med Sestra; 1980 Jan; 39(1):21-4. PubMed ID: 6898782
    [No Abstract]   [Full Text] [Related]  

  • 30. Double-blind comparison of levodopa and procyclidine in parkinsonism, with illustrations of levodopa-induced movement disorders.
    Timberlake WH
    Neurology; 1970 Dec; 20(12):31-5. PubMed ID: 4924342
    [No Abstract]   [Full Text] [Related]  

  • 31. Drugs for parkinsonism.
    Med Lett Drugs Ther; 1988 Dec; 30(781):113-6. PubMed ID: 3143051
    [No Abstract]   [Full Text] [Related]  

  • 32. [Drug therapy of parkinsonism].
    Teräväinen H; Larsen TA
    Duodecim; 1982; 98(11):892-900. PubMed ID: 6125373
    [No Abstract]   [Full Text] [Related]  

  • 33. Permanent dementia in idiopathic Parkinsonism treated with levodopa.
    Wolf SM; Davis RL
    Arch Neurol; 1973 Oct; 29(4):276-8. PubMed ID: 4728189
    [No Abstract]   [Full Text] [Related]  

  • 34. Parkinson disease treated with a suspected dopamine receptor agonist.
    Chase TN; Woods AC; Glaubiger GA
    Arch Neurol; 1974 May; 30(5):383-6. PubMed ID: 4821783
    [No Abstract]   [Full Text] [Related]  

  • 35. Levodopa and amantadine in the treatment of Parkinsonism.
    Critchley E
    Practitioner; 1972 Apr; 208(246):499-504. PubMed ID: 5031037
    [No Abstract]   [Full Text] [Related]  

  • 36. A controlled study of the clinical effects of amantadine hydrochloride (Symmetrel).
    Merrick EM; Schmitt PP
    Curr Ther Res Clin Exp; 1973 Aug; 15(8):552-8. PubMed ID: 4200529
    [No Abstract]   [Full Text] [Related]  

  • 37. Relationship between desipramine plasma levels and the effect in Parkinson's syndrome.
    Muscettola GB; Giovannucci M; Montanini R; Morselli PL; Garattini S
    Rev Eur Etud Clin Biol; 1972 Apr; 17(4):375-9. PubMed ID: 5079227
    [No Abstract]   [Full Text] [Related]  

  • 38. No difference in the effect of biperiden and amantadine on parkinsonian- and tardive dyskinesia-type involuntary movements: a double-blind crossover, placebo-controlled study in medicated chronic schizophrenic patients.
    Silver H; Geraisy N; Schwartz M
    J Clin Psychiatry; 1995 Apr; 56(4):167-70. PubMed ID: 7713856
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [L-dopa-induced movement disorders in Parkinson disease. Amantadine improves dyskinesia].
    MMW Fortschr Med; 2001 May; 143 Suppl 2():93. PubMed ID: 11434272
    [No Abstract]   [Full Text] [Related]  

  • 40. [Amantadine in the therapy of Parkinson syndromes].
    Pfaff G
    Med Klin; 1980 Oct; 75(22):792-4. PubMed ID: 7453628
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.